◆ 会议时间:2024年4月25-27日
◆ 会议地点:瑞士 卢加诺(Lugano)
◆ 会议简介:
2024年晚期前列腺癌共识大会(APCCC)将于2024年4月25-27日在瑞士卢加诺Lugano举行,会议由晚期前列腺癌学会(APC)主办。APC学会是一个非营利性组织,其宗旨是改善晚期前列腺癌患者的治疗和护理。APCCC为从事晚期前列腺癌领域的医学专业人士和其他参与者来提供了一个独特的机会,他们可以参加最新的讲座,并与国际前列腺癌专家互动,了解他们日常实践的真实经验。APCCC旨在提供一个论坛,以讨论和辩论当前有关晚期前列腺癌患者临床管理的问题,会议有两天时间致力于高水准的陈述、讨论和辩论,以总结和概念化现有的文献和证据。会议最后由一个跨学科专家小组针对临床相关目标领域的预定义共识问题进行投票表决。会议结束后,一份带有这些专家建议的手稿将在同行评审的期刊上发表(2015年:Annals of Oncology;2017年:European Urology)。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com).
Advanced Prostate Cancer Consensus Conference (APCCC2024)
Date: 25-27 April 2024
Venue: Lugano, Switzerland
Organized by: Advanced Prostate Cancer Society
Overview of APCCC
In advanced prostate cancer, rapid and successful drug development has resulted in multiple treatment options that require careful decision-making for individual patients. Clinicians face the increasingly difficult task of choosing from multiple potentially effective treatments that also are costly and potentially toxic. Further developments in novel next-generation imaging methods, biomarkers, molecular characterization, and genetic assays have led to many open questions and areas for which there is sparse or low-level evidence to support clinical decision-making.
The Advanced Prostate Cancer Consensus Conference (APCCC) was initiated to provide a forum to discuss and debate current questions on the clinical management of men with advanced prostate cancer, with a special focus on these unclear situations. Two days of the conference are dedicated to high-level presentations, discussions, and debates to summarize and conceptualize the available literature and evidence.
The conference concludes with voting by an interdisciplinary expert panel on pre-defined consensus questions targeting areas of clinical relevance. Following the conference, a manuscript with these expert recommendations is published in a peer-reviewed journal (Annals of Oncology in 2015; European Urology in 2017, 2019, 2021 and 2022 Part I and European Journal of Cancer Part II).
注册费:
Registration Fee APCCC |
Early Registration
before 22 February 2024
CHF |
Late Registration
from 23 February 2024 until conference
CHF |
Online
CHF |
Industry
Please note that industry participation is restricted and only limited slots are available. The slots will be delegated according to the "first come-first served" principle. |
2040 |
2040 |
920 |
Doctor not working for industry |
620 |
770 |
310 |
Nurse
Please upload a confirmation of your head department |
310 |
470 |
110 |
Charity |
310 |
470 |
110 |
Press
Accredited journalists are welcome to cover APCCC 2024. Please use the online registration and upload your press identification. |
free registration |
free registration |
free registration |
Patient Representative |
free registration |
free registration |
free registration |
Participant from a low-income or lower middle income country |
210 |
360 |
free registration |
Student or Fellow in training
Please upload a valid student ID |
210 |
360 |
60 |
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|